DK1009750T3 - Nye (alfa-aminophosphino)peptid derivater, fremgangsmåde til deres fremstilling og deres terapeutiske anvendelse - Google Patents

Nye (alfa-aminophosphino)peptid derivater, fremgangsmåde til deres fremstilling og deres terapeutiske anvendelse

Info

Publication number
DK1009750T3
DK1009750T3 DK97911309T DK97911309T DK1009750T3 DK 1009750 T3 DK1009750 T3 DK 1009750T3 DK 97911309 T DK97911309 T DK 97911309T DK 97911309 T DK97911309 T DK 97911309T DK 1009750 T3 DK1009750 T3 DK 1009750T3
Authority
DK
Denmark
Prior art keywords
aminophosphino
alpha
novel
preparation
methods
Prior art date
Application number
DK97911309T
Other languages
Danish (da)
English (en)
Inventor
Marie-Claude Fournie-Zaluski
Huixiong Chen
Pierre Roques Bernard
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK1009750T3 publication Critical patent/DK1009750T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97911309T 1996-10-25 1997-10-21 Nye (alfa-aminophosphino)peptid derivater, fremgangsmåde til deres fremstilling og deres terapeutiske anvendelse DK1009750T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9613082A FR2755135B1 (fr) 1996-10-25 1996-10-25 Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent
PCT/FR1997/001884 WO1998018803A1 (fr) 1996-10-25 1997-10-21 NOUVEAUX DERIVES D'(α-AMINOPHOSPHINO)PEPTIDES, LEUR PROCEDE DE PREPARATION ET LEURS APPLICATIONS THERAPEUTIQUES

Publications (1)

Publication Number Publication Date
DK1009750T3 true DK1009750T3 (da) 2002-12-16

Family

ID=9497061

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97911309T DK1009750T3 (da) 1996-10-25 1997-10-21 Nye (alfa-aminophosphino)peptid derivater, fremgangsmåde til deres fremstilling og deres terapeutiske anvendelse

Country Status (13)

Country Link
US (1) US6518260B1 (de)
EP (1) EP1009750B1 (de)
JP (1) JP2001504815A (de)
AR (1) AR009129A1 (de)
AT (1) ATE221537T1 (de)
AU (1) AU4873197A (de)
CA (1) CA2266514A1 (de)
DE (1) DE69714475T2 (de)
DK (1) DK1009750T3 (de)
ES (1) ES2180950T3 (de)
FR (1) FR2755135B1 (de)
WO (1) WO1998018803A1 (de)
ZA (1) ZA979573B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777780B1 (fr) * 1998-04-22 2001-05-04 Inst Nat Sante Rech Med Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent
FR2781230B1 (fr) 1998-07-02 2000-09-01 Commissariat Energie Atomique Derives de peptides utilisables comme inhibiteur selectif du site n-terminal de l'enzyme de conversion de l'angiotensine humaine
FR2823212B1 (fr) * 2001-04-10 2005-12-02 Inst Nat Sante Rech Med Inhibiteurs de la toxine botulique de type b
FR2882752B1 (fr) * 2005-03-01 2007-05-04 Servier Lab Nouveaux derives d'aminoacides phosphiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2931151A1 (fr) 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
FR2934267B1 (fr) 2008-07-23 2010-08-13 Pharmaleads Derives aminophosphiniques utiles dans le traitement de la douleur
EP2435402B1 (de) 2009-05-28 2016-04-13 Novartis AG Substituierte aminobuttersäurederivate als neprilysininhibitoren
CN103896796B (zh) 2009-05-28 2016-04-27 诺华股份有限公司 作为脑啡肽酶抑制剂的取代的氨基丙酸衍生物
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
FR2997081B1 (fr) 2012-10-23 2015-11-27 Pharmaleads Inhibiteurs mixtes de l'aminopeptidase n et de la neprilysine
CU24330B1 (es) 2013-02-14 2018-03-13 Novartis Ag Derivados del ácido 4-((1,1) bifenil-4-il)-3-(3-fosfonopropanamido) butanoico, activos como inhibidores de nep (endopeptidasa neutral)
US9102635B2 (en) 2013-02-14 2015-08-11 Novartis Ag Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo efficacy
GR1008310B (el) * 2013-10-03 2014-10-02 Εκεφε Δημοκριτος, Φωσφινικα ψευδοπεπτιδικα παραγωγα για την αποτελεσματικη αναστολη αμινοπεπτιδασων της υπο-οικογενειας οκυτοκινασων της οικογενειας μ1 αμινοπεπτιδασων
JP6938817B2 (ja) * 2015-11-30 2021-09-22 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． Ｍｍｐ−１２阻害剤としての使用のためのホスフィンペプチド誘導体
FR3044227B1 (fr) * 2015-11-30 2017-11-24 Pharmaleads Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires
TWI771386B (zh) 2017-03-09 2022-07-21 法商領先藥物公司 用於預防及治療眼發炎的氨基膦衍生物
FR3063635B1 (fr) * 2017-03-09 2019-06-07 Pharmaleads Derives aminophosphiniques pour la prevention et le traitement de l'inflammation oculaire
FR3077201B1 (fr) 2018-01-26 2020-01-17 Pharmaleads Derives aminoacides contenant un groupement disulfanyle sous forme d'un inhibiteur de nep et d'apn pour la prevention et le traitement des douleurs relatives au nerf trijumeau
FR3098217B1 (fr) 2019-07-05 2023-04-21 Pharmaleads N-Formylhydroxylamines en tant qu’inhibiteurs mixtes de l’aminopeptidase N (APN) et de la néprilysine (NEP)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651229B1 (fr) * 1989-08-24 1991-12-13 Inst Nat Sante Rech Med Nouveaux derives d'amino-acides, leur procede de preparation et leur application therapeutique.
IT1270260B (it) * 1994-06-21 1997-04-29 Zambon Spa Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
FR2730235A1 (fr) * 1995-02-06 1996-08-09 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteur de l'endopeptidase a zinc 24-15

Also Published As

Publication number Publication date
AU4873197A (en) 1998-05-22
CA2266514A1 (en) 1998-05-07
FR2755135B1 (fr) 2002-12-27
WO1998018803A1 (fr) 1998-05-07
AR009129A1 (es) 2000-03-08
DE69714475T2 (de) 2003-04-10
US6518260B1 (en) 2003-02-11
DE69714475D1 (de) 2002-09-05
EP1009750B1 (de) 2002-07-31
FR2755135A1 (fr) 1998-04-30
EP1009750A1 (de) 2000-06-21
ZA979573B (en) 1998-05-21
ATE221537T1 (de) 2002-08-15
JP2001504815A (ja) 2001-04-10
ES2180950T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
DK1009750T3 (da) Nye (alfa-aminophosphino)peptid derivater, fremgangsmåde til deres fremstilling og deres terapeutiske anvendelse
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
IS4345A (is) Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur
NO975710L (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
NO984695D0 (no) Nye isoflavonanrikede soyaproteinprodukter og deres fremstilling
NO990012D0 (no) Nye erytromyciner og fremgangsmÕte for deres fremstilling
NO991815D0 (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
NO308298B1 (no) Substituerte kinazolinderivater, anvendelse derav og farmasøytiske preparater inneholdende dem
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO952677D0 (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
NO307510B1 (no) Bicykliske aromatiske forbindelser, deres anvendelse og farmasøytiske og kosmetiske preparater derav
NO955326D0 (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
NO951418D0 (no) Peptidderivater, deres fremstilling og anvendelse som terapeutika
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO962477D0 (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO984624D0 (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav
DK530689A (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
DK304090A (da) Glycerolderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO973230D0 (no) Nye peptider, deres fremstilling og anvendelse
NO980471D0 (no) Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO307512B1 (no) Nye indolforbindelser, farmasøytisk preparat inneholdende slike forbindelser, og deres anvendelse